GAAP revenue decrease of 2% and organic revenue decrease of 4%; GAAP EPS decreased 29% and adjusted EPS decreased 16%; Company affirms 2026 organic revenue growth outlook of 1% to 3% and adjusted EPS outlook of $8.00 to $8.30
GAAP revenue decrease of 2% and organic revenue decrease of 4%; GAAP EPS decreased 29% and adjusted EPS decreased 16%; Company affirms 2026 organic revenue growth outlook of 1% to 3% and adjusted EPS outlook of $8.00 to $8.30
Thousands of Afghans who assisted US forces are stuck in limbo in Qatar. Instead of promised resettlement in America, they face an uncertain future in another war-torn country Hasina Nasimi* had been counting down to 27 January 2025, the day she was booked on a flight with her husband and four children, to Denver, Colorado. Her brother, four sisters and mother were already there, rebuilding their ...
Thousands of Afghans who assisted US forces are stuck in limbo in Qatar. Instead of promised resettlement in America, they face an uncertain future in another war-torn country Hasina Nasimi* had been counting down to 27 January 2025, the day she was booked on a flight with her husband and four children, to Denver, Colorado. Her brother, four sisters and mother were already there, rebuilding their lives after fleeing Afghanistan. Nasimi’s father and brother were killed by the Taliban; her brother shot in 2018 because the family’s eldest son Mohammad had worked as a translator for American forces during the US-led invasion of Afghanistan. Since then, the family had received threats and lived cautiously. When the Taliban returned to power in August 2021, they knew they had to leave. Continue reading...
Some chats can get up to 600 voice notes a day and reach the 1,024-member limit in less than 24 hours The WhatsApp groups have one simple rule: typing and speaking are forbidden, on pain of immediate removal. Only voice notes with whistling are allowed, although the choice of content is up to the sender: it can be an imitation of a bird or a tune such as the theme from The Pink Panther or the intr...
Some chats can get up to 600 voice notes a day and reach the 1,024-member limit in less than 24 hours The WhatsApp groups have one simple rule: typing and speaking are forbidden, on pain of immediate removal. Only voice notes with whistling are allowed, although the choice of content is up to the sender: it can be an imitation of a bird or a tune such as the theme from The Pink Panther or the introduction to Scorpions’ Wind of Change . Continue reading...
Alzheimer’s Research UK says patients at risk of being left behind as lack of formal or accurate diagnoses closes door to trials People with Alzheimer’s disease are missing out on experimental treatments because they are not diagnosed early or accurately enough to be enrolled in clinical trials, a UK charity has said. Trials of Alzheimer’s drugs reached a record high this year, according to data p...
Alzheimer’s Research UK says patients at risk of being left behind as lack of formal or accurate diagnoses closes door to trials People with Alzheimer’s disease are missing out on experimental treatments because they are not diagnosed early or accurately enough to be enrolled in clinical trials, a UK charity has said. Trials of Alzheimer’s drugs reached a record high this year, according to data published on Tuesday , but Alzheimer’s Research UK said too few UK patients were taking part because their diagnoses were delayed or were not specific enough. Continue reading...
USA Compression Partners press release ( USAC ): Q1 GAAP EPS of $0.27 misses by $0.04 . Revenue of $331.28M (+35.1% Y/Y) beats by $24.59M . Net cash provided by operating activities was $86.1 million for first-quarter 2026, compared to $54.7 million for first-quarter 2025. Adjusted EBITDA was $188.6 million for first-quarter 2026, compared to $149.5 million for first-quarter 2025. Distributable Ca...
USA Compression Partners press release ( USAC ): Q1 GAAP EPS of $0.27 misses by $0.04 . Revenue of $331.28M (+35.1% Y/Y) beats by $24.59M . Net cash provided by operating activities was $86.1 million for first-quarter 2026, compared to $54.7 million for first-quarter 2025. Adjusted EBITDA was $188.6 million for first-quarter 2026, compared to $149.5 million for first-quarter 2025. Distributable Cash Flow was $130.8 million for first-quarter 2026, compared to $88.7 million for first-quarter 2025. Distributable Cash Flow Coverage Ratio was 1.72x for first-quarter 2026, compared to 1.44x for first-quarter 2025. Announced cash distribution of $0.525 per common unit for first-quarter 2026, consistent with first-quarter 2025. Average revenue per revenue-generating horsepower per month of $22.73 for first-quarter 2026, compared to $21.06 for first-quarter 2025. Average revenue-generating horsepower of 4.44 million for first-quarter 2026, compared to 3.56 million for first-quarter 2025. Average horsepower utilization of 91.9% for first-quarter 2026, compared to 94.4% for first-quarter 2025. Full-Year 2026 Outlook USA Compression confirms its full-year 2026 guidance as follows (in thousands): Full-Year 2026 Outlook Low High Adjusted EBITDA (1) $ 770,000 $ 800,000 Distributable Cash Flow (1) $ 480,000 $ 510,000 Capital Expenditures: Expansion capital expenditures (2) $ 230,000 $ 250,000 Maintenance capital expenditures $ 60,000 $ 70,000 Click to enlarge More on USA Compression Partners USA Compression Partners: A High-Yielding Income Idea USA Compression Partners: For The Covered Yield And Moderate Upside USA Compression Partners, LP Common Units (USAC) Presents at J.P. Morgan 2026 Global Leveraged Finance Conference - Slideshow USA Compression Partners Q1 2026 Earnings Preview USA Compression Partners declares $0.525 dividend
Income investors hunting for double-digit yields keep landing on the YieldMax Ultra Option Income Strategy ETF (NYSEARCA:ULTY), a weekly-paying fund that has built a $2.48 billion asset base in roughly two years. The pitch is simple: collect cash every Friday from a portfolio of high-volatility names. The reality is more complicated, and the distribution data ... ULTY’s Weekly Payouts Collapsed 80...
Income investors hunting for double-digit yields keep landing on the YieldMax Ultra Option Income Strategy ETF (NYSEARCA:ULTY), a weekly-paying fund that has built a $2.48 billion asset base in roughly two years. The pitch is simple: collect cash every Friday from a portfolio of high-volatility names. The reality is more complicated, and the distribution data ... ULTY’s Weekly Payouts Collapsed 80% in 2025, Now Recovering to $0.40
Piotr Swat | SOPA Images | Lightrocket | Getty Images Major health insurers appear to be off to an encouraging start this year — but a crucial test for the sector is still ahead. Solid first-quarter results have helped lift investor sentiment, even as insurers continue to grapple with higher medical costs. Companies including UnitedHealth , Elevance , Cigna and Humana all beat estimates for the qu...
Piotr Swat | SOPA Images | Lightrocket | Getty Images Major health insurers appear to be off to an encouraging start this year — but a crucial test for the sector is still ahead. Solid first-quarter results have helped lift investor sentiment, even as insurers continue to grapple with higher medical costs. Companies including UnitedHealth , Elevance , Cigna and Humana all beat estimates for the quarter, with some hiking their 2026 outlooks. Those results were largely expected due to seasonal factors such as a milder flu season and weather disruptions that temporarily suppressed medical costs, said Barclays analyst Andrew Mok. A more meaningful signal, Mok said, is that insurers strengthened medical reserves — money set aside to pay future claims — adding a cushion that could support their outlooks. But there's still a "huge caveat," according to Baird analyst Michael Ha. Insurers have incomplete data on medical costs in the first quarter due to a lag in claims processing, as expenses like hospital stays and procedures can take one or two months to be fully reviewed and reimbursed. By the end of the quarter, companies may only have "real hard claims data" from January, so "we always tell investors to take the first quarter with a grain of salt," Ha said. That sets up the second quarter as the real proving ground. As those delayed claims come in, insurers and investors can get a clearer read on whether medical costs are actually tracking as expected, whether companies have priced their plans appropriately and how their earnings could be shaping up for the rest of the year. "The second quarter is the real underwriting hurdle to pay attention to as you get more claims data that crystallizes your performance for the year in a bigger way," Ha said. "If you clear that hurdle, that could imply positive earnings implications for 2026." A solid first quarter Beneath the surface, insurers' stronger start to the year also reflects steps they've taken to rein in costs after two ...
CEO Jacob Walthour, Kourtney Gibson and The 49th Vice President of the United States, Kamala Harris onstage at the 2026 Power100 Honoree Dinner at Beverly Wilshire, A Four Seasons Hotel on May 3, 2026 in Beverly Hills, California. Arnold Turner | Getty Images The Power100 gathering on the sidelines of the Milken Institute Global Conference took on a different tone this year as its diverse leaders ...
CEO Jacob Walthour, Kourtney Gibson and The 49th Vice President of the United States, Kamala Harris onstage at the 2026 Power100 Honoree Dinner at Beverly Wilshire, A Four Seasons Hotel on May 3, 2026 in Beverly Hills, California. Arnold Turner | Getty Images The Power100 gathering on the sidelines of the Milken Institute Global Conference took on a different tone this year as its diverse leaders in finance attendees fight to reclaim the narrative about people of color and women . "We are trying to show the world what success looks like," said Jacob Walthour , co-founder of Power100 and founder and CEO of Blueprint Capital. "And over the course of the last year, what success looks like has been redefined in a way that has not been respectful and not truthful about the contributions of women and people of color." President Donald Trump , who campaigned on and speaks often about rolling back diversity, equity and inclusion measures in both the federal government and the private sector, was not mentioned at the conference, but the impact of his policies were clearly on the minds of attendees. In his first week back in office in 2025, Trump issued a series of executive orders targeting DEI initiatives at federal agencies and private-sector businesses. The Power100 meeting — in its third year — is hosted by Blueprint Capital Advisors in Beverly Hills, Calif., convening diverse leaders in alternative capital management , a field predominantly led by white men. According to a 2025 Government Accountability Office report , minority- and women-owned firms only manage 1.4% of the approximately $82 trillion in assets under management in the U.S. Shundrawn Thomas , founder of the Copia Group investment firm attended for the first time this year, with the goal of building networks and opportunities to combat trends he sees as concerning. "We've been through a period where there has been an implication that capital and opportunity was flowing to women and people of color that wer...
RESEARCH TRIANGLE PARK, N.C., May 05, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted six newly-hired employees restricted stock units (RSUs) covering an aggregate of 61,750 shares of BioCryst common stock. The RSUs were granted as of May 1, 2026, as inducements material to each employee...
RESEARCH TRIANGLE PARK, N.C., May 05, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted six newly-hired employees restricted stock units (RSUs) covering an aggregate of 61,750 shares of BioCryst common stock. The RSUs were granted as of May 1, 2026, as inducements material to each employee entering into employment with BioCryst. The RSUs were granted in accordance with Nasdaq Listing Rule 5635(c)(4).
WALTHAM, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its first quarter of 2026, covering the three-month period ended March 31, 2026. The Company is also providing updated financial guidance for the full year 2026.
WALTHAM, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its first quarter of 2026, covering the three-month period ended March 31, 2026. The Company is also providing updated financial guidance for the full year 2026.
ST. LOUIS, May 05, 2026 (GLOBE NEWSWIRE) -- BellRing Brands, Inc. (NYSE:BRBR) (“BellRing”), a holding company operating in the global proactive wellness category, today reported results for the second fiscal quarter ended March 31, 2026.
ST. LOUIS, May 05, 2026 (GLOBE NEWSWIRE) -- BellRing Brands, Inc. (NYSE:BRBR) (“BellRing”), a holding company operating in the global proactive wellness category, today reported results for the second fiscal quarter ended March 31, 2026.
Same-restaurant sales growth of 2.8% Total revenues increased 17.3% Net loss of $(2.7) million and Adjusted EBITDA of $27.8 million 16 new system-wide restaurants opened in 11 states
Same-restaurant sales growth of 2.8% Total revenues increased 17.3% Net loss of $(2.7) million and Adjusted EBITDA of $27.8 million 16 new system-wide restaurants opened in 11 states
MALTA, N.Y., May 05, 2026 (GLOBE NEWSWIRE) -- GLOBALFOUNDRIES Inc. (GF) (Nasdaq: GFS) today announced preliminary financial results for the first quarter ended March 31, 2026.
MALTA, N.Y., May 05, 2026 (GLOBE NEWSWIRE) -- GLOBALFOUNDRIES Inc. (GF) (Nasdaq: GFS) today announced preliminary financial results for the first quarter ended March 31, 2026.
-- IMCIVREE ® (setmelanotide) launched in the U.S. for acquired hypothalamic obesity; more than 150 patient start forms received in the first six weeks following FDA approval on March 19, 2026 -- -- First quarter 2026 net product revenue from global sales of IMCIVREE of $60.1 million -- -- IMCIVREE granted Marketing Authorization by European Commission for the treatment of obesity and control of h...
-- IMCIVREE ® (setmelanotide) launched in the U.S. for acquired hypothalamic obesity; more than 150 patient start forms received in the first six weeks following FDA approval on March 19, 2026 -- -- First quarter 2026 net product revenue from global sales of IMCIVREE of $60.1 million -- -- IMCIVREE granted Marketing Authorization by European Commission for the treatment of obesity and control of hunger in patients with acquired hypothalamic obesity --